RenovoRx CFO receives 12,380-share equity grant
VOLL MARK reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
VOLL MARK reported acquisition or exercise transactions in this Form 4 filing.
RenovoRx, Inc. chief financial officer Mark Voll reported an equity grant of 12,380 shares of common stock. These shares were granted as restricted stock units for his service as a consultant of the company for January 2026 and carry a stated price of $0.00 per share.
Following this grant, Voll directly holds 37,380 shares of common stock and has an additional 97,200 shares reported as indirectly held through the Voll Family Trust DTD 6/23/2010, with Mark Voll as trustee. This filing reflects compensation rather than an open-market stock purchase.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 12,380 | $0.00 | $0.00 |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- F1. The reported transaction involved the Reporting Person's receipt of a grant of 12,380 restricted stock units for his service as a consultant of the Issuer for January 2026.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did RenovoRx (RNXT) report for CFO Mark Voll?
Was the RenovoRx (RNXT) Form 4 transaction an open-market purchase?
How are Mark Voll’s indirect holdings in RenovoRx (RNXT) reported?
AI-generated analysis. How Rhea-AI works. Not financial advice.